Paul Bishop(United Kingdom · ♂)— A Manchester ophthalmology professor researching the complement system's role in macular degeneration, he co-founded Complement Therapeutics to turn that science into gene therapies for blindness.
Simon J. Clark(United Kingdom · ♂)— A complement-system scientist, he co-founded Complement Therapeutics as a Manchester spinout developing treatments for geographic atrophy.
Richard Unwin(United Kingdom · ♂)— A biomarker and proteomics researcher, he co-founded Complement Therapeutics to support diagnostics and patient selection for complement-targeting eye therapies.
Team & hubs
In the network
Shares the most investors with (number = shared investors):